The University of Chicago joins the Global Scholars Program

Published on

The NIBR Global Scholars Program (NGSP) is a competitive program designed for innovators from invited institutions to secure funding for breakthrough science not covered by traditional grant support.

The University of Chicago has joined the competitive program which is supported by the Novartis Institutes for Biomedical Research (NIBR) and designed to provide researchers with funding as well as access to expertise in disease biology, drug discovery and translational research.

Through the NIBR Global Scholars Program (NGSP), NIBR – Novartis’ “Innovation Engine” – supports projects that focus on new science with the goal of translating it into drug discovery and/or clinical research.

“The University of Chicago’s invitation to participate in the NIBR Global Scholars program is a key milestone in our growing relationship with Novartis. We are excited to join other world-class institutions and showcase the University’s groundbreaking research,” said David Gross, director of industry relations and strategy at the Polsky Center.

“Novartis understands the importance of investing in early-stage drug discovery, and we look forward to the collaborative projects that may arise from this program,” added Gross.

University of Chicago researchers will now submit research proposals to a competitive review and selection process led by NIBR. Innovative projects selected for funding from all NGSP participating institutions will receive up to $1 million in funding over three years, in addition to the drug research expertise of dedicated NIBR scientific collaborators. An assigned Alliance Manager will also help ensure the collaboration is productive while managing all operational components of the program.

“Such collaborations are critical for faculty researchers developing innovative solutions to society’s biggest problems,” said Jay Schrankler, associate vice president and director of the Polsky Center. “We are grateful for the support and knowledge gained through this program in an effort to commercialize new technologies for the benefit of all humanity.”

Back To Top